|
CTPS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.964100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.404000E-01 |
| Normal-vs-Stage2 |
2.652000E-01 |
| Normal-vs-Stage3 |
3.075400E-01 |
| Normal-vs-Stage4 |
3.432800E-01 |
| Stage1-vs-Stage2 |
4.219000E-01 |
| Stage1-vs-Stage3 |
6.293200E-01 |
| Stage1-vs-Stage4 |
2.220400E-01 |
| Stage2-vs-Stage3 |
6.378800E-01 |
| Stage2-vs-Stage4 |
1.451550E-01 |
| Stage3-vs-Stage4 |
1.217650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.770100E-02 |
| Normal-vs-AfricanAmerican |
1.890640E-01 |
| Normal-vs-Asian |
5.375000E-01 |
| Caucasian-vs-AfricanAmerican |
8.362200E-01 |
| Caucasian-vs-Asian |
3.240600E-01 |
| AfricanAmerican-vs-Asian |
1.480760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.164000E-01 |
| Normal-vs-Female |
5.72369999999323E-05 |
| Male-vs-Female |
1.66822999999594E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.769000E-01 |
| Normal-vs-Extreme_Weight |
5.854200E-01 |
| Normal-vs-Obese |
7.271700E-02 |
| Normal-vs-Extreme_Obese |
5.369200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.639600E-01 |
| Normal_Weight-vs-Obese |
5.485200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.380200E-01 |
| Extreme_Weight-vs-Obese |
1.568380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.790400E-01 |
| Obese-vs-Extreme_Obese |
6.671700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.637700E-02 |
| Normal-vs-Age(41-60Yrs) |
5.201700E-03 |
| Normal-vs-Age(61-80Yrs) |
5.805800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.263600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.451000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.950430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.829700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.045630E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.845900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.579400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.912220E-02 |
| Normal-VS-Type2 PRCC |
7.322600E-01 |
| Normal-VS-KIRP CIMP |
4.997600E-01 |
| Normal-VS-Unclassified PRCC |
1.471970E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.018150E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.013600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.397000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.246800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.125970E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.984200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.605800E-01 |
| Normal-vs-N1 |
8.629800E-02 |
| Normal-vs-N2 |
2.672600E-01 |
| N0-vs-N1 |
6.596100E-02 |
| N0-vs-N2 |
3.406800E-01 |
| N1-vs-N2 |
8.127200E-01 |
|
|
